81 results about "Restless legs syndrome" patented technology

The invention is directed to a method of treating restless legs syndrome in a subject, comprising administering a therapeutically effective amount of a carbamate compound, or pharmaceutically acceptable salt or amide thereof.

The invention relates to the use of certain alpha-aminoamide derivatives in the treatment of RLS and addictive disorders. The compounds of this invention are able to reduce or even stop the symptoms of RLS and addictive disorders substantially without side effects.

An exemplary system for generating a counter-stimulation in a patient suffering from RLS includes a device configured and arranged to generate a counter-stimulation in a patient suffering from RLS, the counter-stimulation of an amplitude, intensity, and time duration lower than that which would wake the patient and higher than that sufficient to relieve RLS, or sufficient to relieve RLS symptoms and allow the patient to return to sleep, a controller configured and arranged to drive the counter-stimulation generation device, the controller being in communication with the counter-stimulation device, and a base configured and arranged to hold the counter-stimulation generation device adjacent to a patient, the counter-stimulation device attached to the base. An exemplary method of treating RLS includes selecting a patient experiencing RLS, and stimulating a portion of the patient at an amplitude, intensity, and duration sufficient to act as a counter-stimulation to RLS.

The invention is directed to methods of treating Restless Leg Syndrome by administering iron complexes with specificed iron release rates or specified iron core size.

A flexible foot relief pad that is wrapped about and secured to the individual's foot in order to relieve the symptoms of restless leg syndrome, restless arms, and foot and leg cramps includes a pliable cloth, wrap having a foot engaging portion joined to a securing portion by a fold, with the foot engaging portion enclosing a cavity for holding therein a layered raised pressure application pad that applies pressure to select areas of the inner side and sole of the foot with the layered pad configured so that a portion of the pad extends transverse to the sole of the foot and a raised portion extends along the inner side of the foot for applying pressure to the specific muscle groups involved in restless leg syndrome. The flexible foot relief pad also includes adjustable securement members that wrap around and encompass both the foot and the relief pad for securing the pad to the foot, and the point of attachment for each securement member is adjustable thereby providing for the even application of pressure against the specific areas of the sole of the foot or for varying the amount of pressure applied to such areas on the sole of the foot.

Apparatuses and methods are disclosed that may be used to treat one or more restless leg syndrome (RLS) symptoms of a patient. One example method may include generating first and second stimulation waveforms using a waveform generator; electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using a number of electrodes; damping or interfering with electrical signals transmitted from the patient's brain to the patient's legs via a femoral nerve of the patient using the electrical stimulation; and reducing the one or more symptoms of RLS based on damping or interfering with the electrical signals transmitted from the patient's brain.

The compound having the structural formula Ior a pharmaceutically acceptable salt thereof, is disclosed, as well as its use in the treatment of central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder, pharmaceutical compositions comprising it, and combinations with other agents.